Logo for Curasight

Curasight Investor Relations Material

Latest events

Logo for Curasight

Q4 2023

Curasight
Logo for Curasight

Q4 2023

27 Feb, 2024
Logo for Curasight

Q3 2023

28 Nov, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Curasight

Access all reports
Curasight is a clinical stage biopharmaceutical company dedicated to developing uPAR Theranostics for the early detection, diagnosis and treatment of cancer. The company's mission is to make a global impact by harnessing imaging technology that improves diagnosis and correlates to improved long-term patient outcome.